Regional Competitors

Delisted . USA . 
Stock . Regional Health Properties
RHEDelisted Stock  USD 2.32  0.07  3.11%   
Regional Health Prop competes with Ramsay Health, Nova Leap, Fresenius, IMAC Holdings, and Oncology Institute; as well as few others. The company runs under Health Care Providers & Services sector within Health Care industry. Analyzing Regional Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Regional Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Regional Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.091.7525.81
Details
Intrinsic
Valuation
LowRealHigh
0.091.9025.96
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regional Health. Your research has to be compared to or analyzed against Regional Health's peers to derive any actionable benefits. When done correctly, Regional Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Regional Health Prop.

Regional Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Regional Health and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Regional and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Regional Health Prop does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TOI
+ 0.66
FSNUY
PIII
+ 0.49
BACK
AVAH
+ 0.37
BACK
AVAH
+ 0.36
RMYHY
PIII
+ 0.35
RMYHY
PIII
+ 0.35
AVAH
  
High negative correlations   
BACK
- 0.83
FSNUY
TOI
- 0.81
BACK
PIII
- 0.55
FSNUY
AVAH
- 0.52
FSNUY
TOI
- 0.51
RMYHY
PIII
- 0.34
TOI

Risk-Adjusted Indicators

There is a big difference between Regional Stock performing well and Regional Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Regional Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RMYHY  1.05 (0.27) 0.00 (0.53) 0.00 
 0.00 
 0.18 
(3.17)
 17.23 
JNHMF  10.33  4.28  0.00  1.40  0.00 
 0.00 
 0.00 
 0.00 
 250.46 
NVLPF  1.72  0.17  0.03  1.72  2.71 
(9.64)
 5.88 
(5.56)
 32.65 
MCIOF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
FSNUY  1.20  0.33  0.28  0.51  1.12 
(1.39)
 3.09 
(2.10)
 8.10 
BACK  6.35 (0.32) 0.00  2.69  0.00 
 0.00 
 12.50 
(14.47)
 81.41 
TOI  7.50  2.73  0.35  0.71  5.37 
(11.42)
 20.24 
(8.00)
 38.02 
AVAH  3.27  0.20  0.05  0.03  3.54 
(4.04)
 6.11 
(5.40)
 20.47 
PIII  3.82 (0.18) 0.00 (0.46) 0.00 
 0.00 
 9.52 
(5.56)
 28.70 
NVOS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
All Fundamental Data

Regional Health Competitive Analysis

The better you understand Regional Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Regional Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Regional Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
RHE RMYHY JNHMF NVLPF FSNUY BACK TOI AVAH PIII MFCSF
 3.11 
 2.32 
Regional
 3.81 
 5.45 
Ramsay
 0.00 
 0.03 
Jack
 5.88 
 0.18 
Nova
 1.51 
 10.79 
Fresenius
 5.00 
 0.57 
IMAC
 3.17 
 0.65 
Oncology
 0.97 
 5.19 
Aveanna
 5.56 
 0.17 
PIII
 10.76 
 10.70 
Medical
Market Volatility
(90 Days Market Risk)
Out of control
Somewhat reliable
Out of control
Out of control
Not too volatile
Out of control
Abnormally volatile
Unstable
Out of control
Not too volatile
Market Performance
(90 Days Performance)
OK
Very Weak
OK
Insignificant
Good
Very Weak
Solid
Insignificant
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Below Average
Low
Low
Low
Very High
Below Average
Average
Quite High
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Under Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Buy
Strong Buy
Hold
Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Hold
Hold
Strong Sell
Strong Buy
Strong Sell
Hold
Strong Hold
Strong Sell
Hold
Current Ratio
0.84
0.88
0.47
0.87
1.32
1.18
3.11
0.81
0.75
1.92
Net Asset
62.18 M
19.47 B
8.14 M
26.77 M
71.96 B
1.14 M
209.24 M
1.61 B
860.97 M
446.97 M
Profit Margin
-0.18
0.0202
-0.37
-0.0216
0.0402
N/A
-0.19
-0.0332
-0.0696
0.0195
EBITDA
1.45 M
1.51 B
(7.54 M)
3.74 M
2.65 B
(5.95 M)
(70.45 M)
44.35 M
(81.07 M)
91.86 M
Operating Margin
0.0499
0.0337
-0.3
-0.0435
0.0881
-35.45
-0.14
0.0671
-0.31
0.14
Current Valuation
69.62 M
17.18 B
6.84 M
18.18 M
43.74 B
3.21 M
124.43 M
2.24 B
111.06 M
236.98 M
Price To Book
N/A
3.93
4.55
1.12
0.71
0.54
3.16
1.17
0.24
1.31
Retained Earnings
(81.9 M)
1.18 B
N/A
N/A
N/A
(55.94 M)
(146.15 M)
(1.37 B)
(367.34 M)
N/A
Current Asset
N/A
1.84 B
N/A
N/A
12.51 B
N/A
N/A
N/A
N/A
N/A
Five Year Return
N/A
N/A
N/A
N/A
1.1
N/A
N/A
N/A
N/A
8.01
Beta
0.95
0.58
-1.43
0.66
1.08
0.16
0.43
2.25
0.93
0.69
Number Of Employees
114
88 K
6
6
319.69 K
2
800
33.5 K
400
24
Shares Outstanding
1.88 M
915.53 M
84.33 M
86.21 M
2.25 B
3.37 M
75.56 M
193.22 M
163.12 M
26.15 M
Cash Flow From Operations
3.71 M
715.5 M
(4.34 M)
2.18 M
5.08 B
(2.79 M)
(36.31 M)
22.67 M
(76.03 M)
75.64 M
Annual Yield
N/A
0.0142
N/A
N/A
0.0321
N/A
N/A
N/A
N/A
0.0391
Total Debt
53.65 M
5.17 B
106.58 K
896.13 K
27.16 B
1.9 M
119.67 M
1.5 B
121.94 M
74.28 M
Return On Equity
-5.34
0.0836
-1.78
-0.0309
0.0793
-3.32
-1.61
-5.48
-0.65
0.22
Z Score
N/A
1.2
32.8
10.8
N/A
N/A
N/A
N/A
N/A
1.2
Return On Asset
-0.003
0.0155
-0.33
-0.0294
0.0292
-0.79
-0.2
0.0488
-0.18
0.0875
Number Of Shares Shorted
12.13 K
N/A
N/A
N/A
N/A
216.77 K
934.76 K
1.31 M
1.91 M
N/A
Book Value Per Share
-10.71
4.04
0.012
0.22
9.49
-2.38
0.21
-0.8
0.74
3.97
Current Liabilities
N/A
1.99 B
N/A
N/A
9.5 B
N/A
N/A
N/A
N/A
N/A
Total Asset
62.18 M
19.47 B
8.14 M
26.77 M
71.96 B
1.14 M
209.24 M
1.61 B
860.97 M
446.97 M
Short Ratio
0.07
N/A
N/A
N/A
N/A
0.04
1.36
7.7
1.4
N/A
Debt To Equity
N/A
2.36
0.88
0.33
0.89
0.35
0.15
7.17
0.082
0.74
Last Dividend Paid
N/A
N/A
N/A
N/A
0.92
N/A
N/A
N/A
N/A
0.24
Target Price
N/A
N/A
N/A
N/A
N/A
8.25
2.0
5.28
0.63
N/A
Shares Owned By Institutions
1.76
N/A
N/A
N/A
N/A
1.4
40.04
89.89
13.04
18.76
Market Capitalization
5.21 M
10.86 B
5.68 M
16.91 M
17.65 B
2.02 M
49.11 M
993.18 M
94.29 M
160.83 M
Price To Earning
N/A
48.23
N/A
10.57
7.33
N/A
190.67
N/A
N/A
20.75
Price To Earnings To Growth
N/A
N/A
N/A
N/A
1.01
N/A
N/A
0.85
N/A
N/A
Price To Sales
0.33
0.72
0.49
0.79
0.38
28.1
0.13
0.5
0.0639
0.37
Net Income
(3.89 M)
274 M
(7.81 M)
1.76 M
1.82 B
(9.42 M)
(83.07 M)
(134.52 M)
(57.77 M)
15.5 M
Earnings Per Share
-1.55
0.2
-0.077
N/A
0.77
-4.16
-0.77
-0.06
-0.86
0.26
Shares Owned By Insiders
14.04
N/A
41.27
36.06
N/A
3.62
14.87
6.1
62.07
0.48
Revenue
17.16 M
13.08 B
9.64 M
21.28 M
37.52 B
5.2 M
324.24 M
1.9 B
1.27 B
398.63 M
Working Capital
3.3 M
(151 M)
N/A
N/A
3.02 B
(752.65 K)
108.7 M
(39.87 M)
(133.35 M)
N/A
Cash And Equivalents
843 K
325.5 M
816.49 K
794.12 K
2.13 B
1.61 M
64.21 M
17.46 M
63.15 M
47.7 M
Cash Per Share
1.53
0.36
0.01
0.01
0.94
0.06
0.89
0.09
1.52
1.57
Gross Profit
6.43 M
1.41 B
6.66 M
7.21 M
10.26 B
(1.47 M)
53.74 M
612.27 M
(40.2 M)
148.71 M
Day Typical Price
2.16
5.41
0.026
0.18
10.79
0.57
0.66
5.2
0.17
11.0
Accumulation Distribution
0.49
4.04
N/A
N/A
11.17
10841.44
690.12
57984.26
5611.39
0.0776
Market Facilitation Index
1.37
6.0E-4
N/A
N/A
0.0
N/A
0.0
N/A
N/A
0.9
Daily Balance Of Power
0.0511
1.818182
0.0
9.2 T
4.0
(0.60)
1.0
0.1282
(1.00)
(1.43)
Period Momentum Indicator
0.07
0.2
N/A
0.01
0.16
(0.03)
0.02
0.05
(0.01)
(1.29)
Rate Of Daily Change
1.03
1.04
1.0
1.06
1.02
0.95
1.03
1.01
0.94
0.89
Day Median Price
2.09
5.4
0.026
0.18
10.79
0.56
0.66
5.21
0.18
11.15
Price Action Indicator
0.27
0.16
N/A
0.005
0.08
(0.01)
N/A
0.01
(0.01)
(1.10)
Coefficient Of Variation
1258.85
(707.86)
791.99
2437.86
586.37
(3,773)
407.53
12091.34
(2,238)
(3,419)
Mean Deviation
7.01
1.05
10.33
1.72
1.2
6.35
7.5
3.27
3.82
1.2
Jensen Alpha
1.56
(0.27)
4.28
0.173
0.327
(0.32)
2.73
0.1999
(0.18)
(0.02)
Total Risk Alpha
4.4
0.0606
9.09
0.8573
0.5191
1.55
3.85
1.01
0.6725
0.2758
Sortino Ratio
0.1597
N/A
N/A
0.0321
0.2769
N/A
0.3468
0.0494
N/A
N/A
Downside Variance
93.73
N/A
N/A
88.43
2.07
N/A
48.61
13.29
N/A
N/A
Standard Deviation
17.8
2.59
30.85
4.14
1.56
11.0
9.32
5.78
5.51
2.05
Kurtosis
42.7
28.77
23.71
8.14
0.3698
8.42
(0.26)
26.98
2.89
11.45
Potential Upside
12.14
0.1802
N/A
5.88
3.09
12.5
20.24
6.11
9.52
2.92
Treynor Ratio
1.3
(0.53)
1.4
1.72
0.5138
2.69
0.7145
0.0332
(0.46)
(0.19)
Maximum Drawdown
159.73
17.23
250.46
32.65
8.1
81.41
38.02
20.47
28.7
8.94
Variance
316.67
6.73
952.01
17.13
2.44
121.06
86.79
33.42
30.38
4.21
Market Risk Adjusted Performance
1.31
(0.52)
1.41
1.73
0.5238
2.7
0.7245
0.0432
(0.45)
(0.18)
Risk Adjusted Performance
0.0766
(0.11)
0.1163
0.0426
0.1486
(0.01)
0.2162
0.0155
(0.03)
(0.02)
Skewness
5.82
(4.08)
4.21
0.7825
0.4071
0.0231
0.6621
4.14
1.38
(1.65)
Semi Deviation
7.27
N/A
N/A
2.71
1.12
N/A
5.37
3.54
N/A
N/A
Information Ratio
0.0869
(0.09)
0.1306
0.073
0.2553
(0.01)
0.2596
0.0311
(0.02)
0.0352
Value At Risk
(16.25)
(3.17)
N/A
(5.56)
(2.10)
(14.47)
(8.00)
(5.40)
(5.56)
(2.30)
Expected Short fall
(8.59)
N/A
N/A
(9.64)
(1.39)
N/A
(11.42)
(4.04)
N/A
N/A
Downside Deviation
9.68
N/A
N/A
9.4
1.44
N/A
6.97
3.64
N/A
N/A
Semi Variance
52.8
N/A
N/A
7.32
1.25
N/A
28.86
12.54
N/A
N/A

Regional Health Competition Performance Charts

Five steps to successful analysis of Regional Health Competition

Regional Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Regional Health Prop in relation to its competition. Regional Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Regional Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Regional Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Regional Health Prop, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Regional Health position

In addition to having Regional Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials Thematic Idea Now

Financials
Financials Theme
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Regional Stock

If you are still planning to invest in Regional Health Prop check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regional Health's history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY